Search

everythinglearnresearchcommunity

for

Search:↓

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document explains various skin conditions and their treatments.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Pediatric lichen is rare and diverse, and dermoscopy helps improve diagnosis and management in children.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

A neglected leprosy treatment led to rare scalp hair loss in an Indian woman, which improved with proper medication.

Lichen planopilaris can unusually affect only the face, causing pigmentation and scarring.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Trichoscopy helps diagnose hair and scalp disorders in dark-skinned people by identifying unique patterns.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.